Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. - Wikidata - wikimedia - TriplyDB

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

http://www.wikidata.org/entity/Q34488692

about

Preoperative chemotherapy for resectable thoracic esophageal cancer Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus Treatment of gastric cancer Neoadjuvant therapy for gastroesophageal adenocarcinoma Current adjuvant treatment modalities for gastric cancer: From history to the future Recent developments and innovations in gastric cancer Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives Advanced gastric cancer: What we know and what we still have to learn Towards curative therapy in gastric cancer: Faraway, so close!Neoadjuvant therapy for gastric cancer: current evidence and future directions Multimodal treatment of gastric cancer in the west: Where are we going?Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward Locally advanced gastroesophageal junction tumor: a treatment dilemma Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy.Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer.Antitumor effects and the underlying mechanism of licochalcone A combined with 5-fluorouracil in gastric cancer cells.A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).Trends in the surgical treatment of gastric adenocarcinoma.The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine Towards personalized perioperative treatment for advanced gastric cancer.Medical management of gastric cancer: a 2014 update.Adjuvant therapy for gastric cancer: current and future directions.Multimodality management of resectable gastric cancer: A review.Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review.Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction.Surgical management of gastric cancer: the East vs. West perspective Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients Radical gastrectomy with hepatoarterial catheter implantation for late-stage gastric cancer.An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer.Proteomic and metabolic prediction of response to therapy in gastric cancer.Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis.

P2860

Q24187910-DCDC9056-4125-461F-9C6E-C6A711863C73 Q24202957-9B8E6F44-1366-4CC5-B88D-1182EC4A1B26 Q24602875-1D18D54A-F703-447C-B39B-156620285B67 Q26746147-519E7B6C-9D5F-400D-8FDC-2AFA6BE5CE81 Q26748744-FD2467C0-831B-41CB-ADBB-6B475C31917C Q26751327-EC5654E1-3AB3-48A0-B09B-53AA7EB117D0 Q26774283-5AE9E6A9-1160-43EA-BB10-685C93DC9FFA Q26774528-7FA55B12-33F1-4D3B-8277-0DB9CE75096A Q26778029-28C3E3A4-507E-4952-B600-F88C25F7CB4D Q26781043-0081FE9B-C343-487A-BF20-40AAB6460AA4 Q26799748-DE5530AF-F30A-406D-BC2D-ED7564E8979E Q26858776-466A83F1-EC3F-4C08-AC97-221FD24E5847 Q27016030-407E988D-79DB-4D1E-8292-0A5152483B6C Q28082596-4B34EA5B-CAFA-4725-B78C-F009D8A49AA8 Q28086772-F1163636-441D-469F-826A-2682104C0A0B Q28088619-57B03FC1-806D-4D2B-8F43-D3581BC7127E Q30248541-FD215516-E935-483D-8F42-F2505014A355 Q30459126-7DE0CE98-4A19-452C-8648-6C3F414AFAD0 Q31150068-E34D4B22-BE55-4926-A5A8-BB241164EA0E Q33399537-1EEA2378-72E0-464B-872E-CF98D9359730 Q33597539-E9C40CFA-1CA2-4E23-8246-E15FFF6EC59D Q33656736-08081B1D-3BBC-4855-9E59-6F6BF36EF52F Q33728359-5816AF1E-708A-44B9-A728-0A4D42462627 Q33978927-1ED53D40-1B92-49EA-8643-FAF57F75FFDD Q34062470-9B2AEC6C-F08D-4E47-B294-83C1351B9F0A Q34082404-5A31F393-587D-49A4-8DB3-8595F0D4C267 Q34137285-5668960A-D754-4830-B8BC-322A2A827B1D Q34326546-6D749267-FFB8-4CB3-9DEB-1FA688577324 Q34326579-88F72F88-9AA3-4BE0-8DCA-CADAB546B7F9 Q34340956-C614F568-6023-4662-B8B7-9DD0EB91B13F Q34631121-CA0A52B0-E865-4F4B-A45B-8AD105B1D84C Q34638268-54F67881-8187-4BBE-87CB-E90963261A7A Q34678579-4D68519F-86DD-436A-B331-3EFC62DA34F4 Q34962070-A3539D96-3426-4E10-B50D-9FD234CCA65F Q35034753-A4C88434-7FA0-4556-BA8E-5CADCE50C4CF Q35060178-2503BA3C-D190-4999-A445-ADFCFC30918E Q35152370-79A8335D-34D6-4E84-AF6C-7537ADF14AA3 Q35163577-22D7F1F1-BD20-41E6-BBF2-7C9583A29442 Q35336183-8955BC6B-D138-4777-BF45-C92DD7410DDE Q35737764-7C19FA31-F16D-47D5-9FC2-AB8B0FC069A7

P2860

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

http://www.wikidata.org/entity/Q34488692

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@ast

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@en

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@nl

type

label

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@ast

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@en

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@nl

prefLabel

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@ast

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@en

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@nl

P1433

Q34488692-AA7D8FD8-0787-4815-9561-79539C9ED089

P1476

Q34488692-2AC41C2E-229E-4D56-A2C9-DAE4FFCD2575

P2093

Q34488692-05F1C843-4A53-4D4B-8811-CFD458F01051

Q34488692-06C219C4-DEC7-44BC-B3A3-D9731C672AC1

Q34488692-19AAF39D-0211-40AE-A487-D4A500F19A83

Q34488692-1F258614-C877-4377-8EC8-EC60DFEE6393

Q34488692-289860CB-A075-48C3-BC81-90E15F8264E0

Q34488692-3FD2C983-8168-4899-B7C4-A8C5C39781B3

Q34488692-476BFBAE-D248-480C-9E9B-F3673755F013

Q34488692-9CC378F6-EDA3-4B60-902C-A6FF41EE1356

Q34488692-B0D9B26A-0928-482E-88E3-80FFA000D76E

Q34488692-B632F431-DE8E-4A62-B3DB-8A98C4772450

P2860

Q34488692-2C1762BE-563A-49EC-8C45-DBF6AA93D7C1

Q34488692-367739E1-95F3-4552-9544-B0F1FE2D4998

Q34488692-3F38F25C-F3C1-4D0C-A066-44B58A326A91

Q34488692-5A23DE76-37F1-4E28-A044-9160FCFB509F

Q34488692-5BDA3B24-8F35-4F33-8B2C-3C3F34E807FA

Q34488692-62A7D030-DB6F-4D88-B47C-56911455FB30

Q34488692-6C23B41A-FEB2-488C-8002-2CCE61344F9E

Q34488692-789296BB-37D9-43A4-88EA-D09944E4DFD6

Q34488692-8A231BB2-64AA-4C3A-93CE-51BCDF604295

Q34488692-94E79B4A-31F4-4276-AE1D-7BA1F2C2A95F

P304

Q34488692-2E14EDA2-A9FE-4210-9198-7218DBDD5F24

P31

Q34488692-9A1A9E16-C09C-43A9-B587-F4CC6CF84685

P356

Q34488692-6C7E3D6C-807C-4C2F-8816-77100B3FD7C9

P407

Q34488692-D30492C6-1055-41E9-9FA9-AE1FFDE65C2F

P433

Q34488692-5BC7A627-B27E-4C46-8B39-582C3DCC6A22

P478

Q34488692-3B75965E-BF9C-42D1-9645-972BBE3A5607

P50

Q34488692-2FA6FBCD-33E4-474C-B361-CCEB583C66A2

Q34488692-36996791-0A9A-4772-86A5-1DAE425B86C4

P577

Q34488692-D8494278-E860-4EB3-A8B6-E5AF9BAC81BD

P698

Q34488692-DCF57077-61EA-4E01-B83F-B0B05FA6A162

P921

Q34488692-D6C2F32C-4595-467B-BAF3-352EBE97B865

P932

Q34488692-150E1C90-8F32-47C6-9B9C-9E1951C13AB0

P356

JCO.2009.26.6114

P1433

Journal of Clinical Oncology

P1476

Neoadjuvant chemotherapy compa ...... Cancer randomized trial 40954.

@en

P2093

Arnulf Hoelscher

http://www.w3.org/2001/XMLSchema#string

Baktiar Hasan

http://www.w3.org/2001/XMLSchema#string

Bernard Nordlinger

http://www.w3.org/2001/XMLSchema#string

Christoph Schuhmacher

http://www.w3.org/2001/XMLSchema#string

Claus F Eisenberger

http://www.w3.org/2001/XMLSchema#string

Cornelie Haag

http://www.w3.org/2001/XMLSchema#string

Florian Lordick

http://www.w3.org/2001/XMLSchema#string

Hans Wilke

http://www.w3.org/2001/XMLSchema#string

John Welch

http://www.w3.org/2001/XMLSchema#string

Jörg R Siewert

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.

Cancer statistics, 2000.

Cancer of the esophagogastric junction.

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer G

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.

Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.

P304

5210-5218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.26.6114

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Wolf Otto Bechstein

Eric Van Cutsem

P577

2010-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21060024

http://www.w3.org/2001/XMLSchema#string

P921

P932

3020693

http://www.w3.org/2001/XMLSchema#string